Mechanistically, interferon-γ enhances β-cell PD-L1 expression in NOD islets (39), whereas loss of PD-1 on CD4+ T cells augment islet antigen–specific infiltration, underscoring the pathway’s role in restraining diabetogenic autoimmunity (43). The gene discussed is CD4; the disease is Autoimmunity.